HomeCompareRCDTF vs VICI

RCDTF vs VICI: Dividend Comparison 2026

RCDTF yields 2.77% · VICI yields 6.57%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VICI wins by $936.2K in total portfolio value
10 years
RCDTF
RCDTF
● Live price
2.77%
Share price
$56.95
Annual div
$1.58
5Y div CAGR
32%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$52.6K
Annual income
$9,708.55
Full RCDTF calculator →
VICI
VICI Properties Inc.
● Live price
6.57%
Share price
$27.12
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$988.8K
Annual income
$623,261.32
Full VICI calculator →

Portfolio growth — RCDTF vs VICI

📍 VICI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRCDTFVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RCDTF + VICI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RCDTF pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RCDTF
Annual income on $10K today (after 15% tax)
$235.82/yr
After 10yr DRIP, annual income (after tax)
$8,252.27/yr
VICI
Annual income on $10K today (after 15% tax)
$558.67/yr
After 10yr DRIP, annual income (after tax)
$529,772.12/yr
At 15% tax rate, VICI beats the other by $521,519.85/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RCDTF + VICI for your $10,000?

RCDTF: 50%VICI: 50%
100% VICI50/50100% RCDTF
Portfolio after 10yr
$520.7K
Annual income
$316,484.94/yr
Blended yield
60.78%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

RCDTF
Analyst Ratings
2
Hold
1
Sell
Consensus: Hold
Altman Z
3.4
Piotroski
5/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+16.5% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RCDTF buys
0
VICI buys
0
No recent congressional trades found for RCDTF or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRCDTFVICI
Forward yield2.77%6.57%
Annual dividend / share$1.58$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR32%44.3%
Portfolio after 10y$52.6K$988.8K
Annual income after 10y$9,708.55$623,261.32
Total dividends collected$28.6K$948.4K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldBuy

Year-by-year: RCDTF vs VICI ($10,000, DRIP)

YearRCDTF PortfolioRCDTF Income/yrVICI PortfolioVICI Income/yrGap
1← crossover$11,066$366.22$11,368$948.43$302.00VICI
2$12,341$499.95$13,339$1,493.16$998.00VICI
3$13,892$687.80$16,326$2,426.21$2.4KVICI
4$15,820$955.18$21,123$4,112.15$5.3KVICI
5$18,269$1,341.86$29,379$7,368.23$11.1KVICI
6$21,460$1,911.67$44,804$14,191.64$23.3KVICI
7$25,732$2,770.17$76,658$29,972.12$50.9KVICI
8$31,631$4,097.76$150,894$71,015.81$119.3KVICI
9$40,060$6,214.06$350,814$193,582.47$310.8KVICI
10$52,572$9,708.55$988,809$623,261.32$936.2KVICI

RCDTF vs VICI: Complete Analysis 2026

RCDTFStock

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides products for rare diseases; and pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.

Full RCDTF Calculator →

VICIREIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this RCDTF vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RCDTF vs SCHDRCDTF vs JEPIRCDTF vs ORCDTF vs KORCDTF vs MAINRCDTF vs NNNRCDTF vs EPRTRCDTF vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.